loading
Überblick Nachrichten Preisverlauf Forum Prognose
Schlusskurs vom Vortag:
$3.78
Offen:
$3.72
24-Stunden-Volumen:
4,000
Relative Volume:
0.30
Marktkapitalisierung:
$68.40M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-12.63M
KGV:
-5.6036
EPS:
-0.6942
Netto-Cashflow:
$-12.18M
1W Leistung:
-1.78%
1M Leistung:
+25.08%
6M Leistung:
+3.46%
1J Leistung:
-15.43%
1-Tages-Spanne:
Value
$3.72
$3.90
1-Wochen-Bereich:
Value
$3.51
$4.00
52-Wochen-Spanne:
Value
$2.74
$7.28

Genenta Science Spa Adr Stock (GNTA) Company Profile

Name
Firmenname
Genenta Science Spa Adr
Name
Sektor
Healthcare (1171)
Name
Branche
Biotechnology (657)
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
13
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
GNTA's Discussions on Twitter

Vergleichen Sie GNTA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GNTA
Genenta Science Spa Adr
 3.74 71.33M 0 -12.63M -12.18M -0.6942
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 462.19 123.14B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 544.52 60.43B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 319.50 42.07B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
 567.87 34.47B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
 294.82 27.42B 3.81B -644.79M -669.77M -6.24

Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-06-29 Fortgesetzt ROTH MKM Buy
2022-07-25 Eingeleitet H.C. Wainwright Buy
2022-01-13 Eingeleitet Maxim Group Buy

Genenta Science Spa Adr Aktie (GNTA) Neueste Nachrichten

pulisher
Jul 09, 2025

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Esperion (ESPR) - The Globe and Mail

Jul 09, 2025
pulisher
Jul 02, 2025

Genenta Science stock maintains Buy rating as Temferon shows promise in GBM - Investing.com

Jul 02, 2025
pulisher
Apr 15, 2025

Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar - GlobeNewswire Inc.

Apr 15, 2025
pulisher
Mar 19, 2025

Genenta secures $21.9 million for cancer drug trial By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta secures €20M in mandatory convertible bond deal - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta secures €20M in mandatory convertible bond deal By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta secures $21.9 million for cancer drug trial - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta Science Secures €20 Million Convertible Bond Financing for Oncology Research - TipRanks

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta Science Secures €20 Million Financing to Boost Cancer Therapy Development - TipRanks

Mar 19, 2025
pulisher
Feb 27, 2025

Oncology Breakthroughs: How Cancer Research Is Advancing in 202527.02.25News - Ariva

Feb 27, 2025
pulisher
Jan 10, 2025

Genenta Science announces amendment to pact with AGC Biologics - Yahoo Finance

Jan 10, 2025
pulisher
Dec 30, 2024

Genenta Science Enhances Manufacturing Agreement with AGC Biologics - TipRanks

Dec 30, 2024
pulisher
Apr 02, 2024

Genenta Science Announces Shareholder Meeting - TipRanks

Apr 02, 2024
pulisher
Mar 26, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 26, 2024
pulisher
Oct 17, 2022

10 Best Italian Stocks To Buy Now - Yahoo Finance

Oct 17, 2022

Finanzdaten der Genenta Science Spa Adr-Aktie (GNTA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie GNTA

biotechnology GMAB
$22.19
price up icon 0.86%
biotechnology RPRX
$35.45
price up icon 0.37%
biotechnology INSM
$104.57
price up icon 0.51%
biotechnology SMMT
$27.95
price up icon 1.07%
biotechnology BNTX
$110.73
price down icon 0.10%
biotechnology ONC
$298.88
price up icon 3.15%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):